Clinical trial of 90 patients (30 B-Cure active Laser, 30 placebo, 30 pain relief medication) affected by Joint-Related Pain (TMJ).
The results:
The double blind clinical trial, involving 90 patients, has shown a significant reduction in both the B-Cure active laser and drug groups vs the B-Cure Placebo Laser. Significance – p<0.01
Pain reduction of the active group was no different than the drug group.
Published in: Cranio, April 2019